AGO Score Identifies Ovarian Cancer Patients Likely to Benefit from Cytoreductive Surgery
December 6, 2021 2:29 pmby Sucharita Mistry, PhD
Cytoreductive surgery followed by chemotherapy can prolong overall survival (OS), compared with chemotherapy alone, in certain patients with relapsed ovarian cancer, according to results from the DESKTOP III trial published in the New England Journal of … Read more